Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
621
Protein Tyrosine Phosphatase Oligomerization Studied by a Combination of <sup>15</sup>N NMR Relaxation and <sup>129</sup>Xe NMR. Effect of Buffer Containing Arginine and Glutamic A...
Published 2007“…They have been applied to study the oligomerization equilibrium of a low-molecular-weight protein tyrosine phosphatase in the presence of 50 mM arginine and 50 mM glutamic acid. These experimental conditions are shown to enhance specific protein−protein interactions while decreasing nonspecific aggregation. …”
-
622
Protein Tyrosine Phosphatase Oligomerization Studied by a Combination of <sup>15</sup>N NMR Relaxation and <sup>129</sup>Xe NMR. Effect of Buffer Containing Arginine and Glutamic A...
Published 2007“…They have been applied to study the oligomerization equilibrium of a low-molecular-weight protein tyrosine phosphatase in the presence of 50 mM arginine and 50 mM glutamic acid. These experimental conditions are shown to enhance specific protein−protein interactions while decreasing nonspecific aggregation. …”
-
623
-
624
-
625
Effects of busulfan treatment on CX43 and N-Cadherin.
Published 2025“…(<i>n</i> = 6 per group; Immunofluorescence staining; 400 × ; Scale bar = 50 μm).…”
-
626
-
627
-
628
-
629
-
630
-
631
-
632
-
633
-
634
-
635
-
636
-
637
-
638
-
639
<i>Drosophila CG8501</i>, an orthologous gene of human <i>CD59</i>.
Published 2023“…<p>(<b>A</b>) Expression of CD orthologues in <i>Drosophila</i> hemocytes. …”
-
640
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
Published 2018“…Also, bivalent proteins (A244.AE and 6240.B) formulated with MF59 elicited distinct V2-specific Abs to the epitope previously shown to correlate with decreased risk of HIV-1 infection in the RV144 trial. …”